(Q28138484)

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Paraneoplastic neurologic syndromes: pathogenesis and physiopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

1 reference

7 January 2021

Myasthenia Gravis: Passive Transfer from Man to Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Neuropathies Associated with Paraproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Progress in determining the causes and treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Assessment of animal models for MS and demyelinating disease in the design of rational therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The stiff man and stiff man plus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Autoimmunity and neurological disease: antibody modulation of synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Immunological tolerance in germinal centres

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Transgenic mice and analysis of B-cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

B-cell activation versus tolerance--the central role of immunoglobulin receptor engagement and T-cell help

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

B cell development: signal transduction by antigen receptors and their surrogates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

CD19-Regulated Signaling Thresholds Control Peripheral Tolerance and Autoantibody Production in B Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Transcriptional regulation during B cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

1 reference

7 January 2021

T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Diversity and plasticity of self recognition during the development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Molecular mimicry and autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Mechanisms of immune regulation in the peripheral nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Production of cytokines by human B cells in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Systemic autoimmune disease arises from polyclonal B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The role of complement and complement receptors in induction and regulation of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Leukocyte traffic in the central nervous system: the participants and their roles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Mapping autoimmunity genes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The structural requirements for complement activation by IgG: does it hinge on the hinge?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Superantibody activities: new players in innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The cell biology of the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Neonatal Guillain-Barré syndrome: blocking antibodies transmitted from mother to child

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Isolation and characterization of an oligodendrocyte precursor–derived B‐cell epitope in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Cell injury mediated by autoantibodies to intracellular antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Neurotrophins and their receptors in nerve injury and repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Axonal damage in acute multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Axonal Transection in the Lesions of Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Immunological and neuropathological significance of the Virchow-Robin space

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Immunization-induced inflammatory infiltration of the central nervous system in transgenic mice expressing a microbial antigen in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Influence of infection on exacerbations of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Restricted use of VH4 Germline segments in an acute multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The significance of perivascular infiltrations in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Immunoglobulin-containing cells in multiple-sclerosis plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Cerebrospinal fluid markers in multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

Mediators of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901575-7

7 January 2021

10.1016/S0166-2236(00)01575-7

Identifiers

DOI

0 references

Fatcat ID

release_zmuxzctwsvbtpajxh2ho4lpabe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zmuxzctwsvbtpajxh2ho4lpabe

24 November 2022